SCHEMBL1633843

SCHEMBL1633843

NS(=O)(=O)c1ccc(Nc2ncc3ccc(-c4ccc(C(=O)N5CCOCC5)cc4)cc3n2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK10 P53779 1/20 0.54
▸ JAK2 O60674 4/20 0.52
▸ LRRK2 Q5S007 1/20 0.52
▸ CSF1R P07333 1/20 0.50
▸ SMG1 Q96Q15 2/20 0.49
▸ MTOR P42345 1/20 0.49
▸ CA12 O43570 3/20 0.48
▸ CA1 P00915 3/20 0.48
▸ CA9 Q16790 3/20 0.48
▸ CA2 P00918 2/20 0.47
▸ CDK2 P24941 3/20 0.47
▸ CCNE1 P24864 2/20 0.47
▸ CCNA2 P20248 2/20 0.47
▸ CCNT1 O60563 1/20 0.47
▸ CDK1 P06493 1/20 0.47
▸ CDK4 P11802 1/20 0.47
▸ CCND1 P24385 1/20 0.47
▸ CCND3 P30281 1/20 0.47
▸ CDK9 P50750 1/20 0.47
▸ CDK3 Q00526 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1633064 0.84 MTOR (0.62) SMG1MTORCA12CA1CA9
SCHEMBL1632340 0.83 MAPK10 (0.63) MAPK10JAK2LRRK2CSF1RCDK2
SCHEMBL1633230 0.83 CA2 (0.52) JAK2CSF1RCA12CA1CA9
SCHEMBL1632820 0.82 SMG1 (0.58) MAPK10JAK2SMG1MTORCA12
SCHEMBL1632195 0.81 CDK2 (0.56) JAK2SMG1MTORCA12CA1
SCHEMBL1633017 0.81 SMG1 (0.72) MAPK10JAK2LRRK2SMG1MTOR
SCHEMBL1633645 0.79 MAP4K1 (0.62) MAPK10JAK2LRRK2CSF1RCDK2
SCHEMBL1632895 0.79 CDK2 (0.53) SMG1MTORCA12CA1CA9
SCHEMBL1634125 0.79 MAP4K1 (0.53) MAPK10JAK2LRRK2CSF1RCDK2
SCHEMBL3502719 0.78 MTOR (0.62) SMG1MTORCA12CA1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
Send feedback